IART
$12.89
Integra Lifesciences
$.16
1.26%
IART
Earnings Whisper ®
N/A
2nd Quarter June 2025
Consensus: $0.44
Revenue: N/A
Share
Watch
Guidance announcement made Monday, May 5, 2025
Latest EPS
Monday, May 5, 2025
What do you expect when IART reports earnings?
Where is IART's stock price going from here?
Analysts
Pivots
Resistance
$13.76
$13.52
$13.12
Support
$12.48
$12.24
$11.84
Description
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.